BR112014014751A8 - composition comprising alpha-1-antitrypsin, mammary gland epithelial cells, transgenic non-human mammal, and method for reducing lung elastase activity - Google Patents

composition comprising alpha-1-antitrypsin, mammary gland epithelial cells, transgenic non-human mammal, and method for reducing lung elastase activity

Info

Publication number
BR112014014751A8
BR112014014751A8 BR112014014751A BR112014014751A BR112014014751A8 BR 112014014751 A8 BR112014014751 A8 BR 112014014751A8 BR 112014014751 A BR112014014751 A BR 112014014751A BR 112014014751 A BR112014014751 A BR 112014014751A BR 112014014751 A8 BR112014014751 A8 BR 112014014751A8
Authority
BR
Brazil
Prior art keywords
antitrypsin
alpha
composition
epithelial cells
mammary gland
Prior art date
Application number
BR112014014751A
Other languages
Portuguese (pt)
Other versions
BR112014014751A2 (en
Inventor
M Meade Harry
R Bourdon Paul
Original Assignee
Lfb Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lfb Usa Inc filed Critical Lfb Usa Inc
Publication of BR112014014751A2 publication Critical patent/BR112014014751A2/en
Publication of BR112014014751A8 publication Critical patent/BR112014014751A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
BR112014014751A 2011-12-19 2012-12-19 composition comprising alpha-1-antitrypsin, mammary gland epithelial cells, transgenic non-human mammal, and method for reducing lung elastase activity BR112014014751A8 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161577289P 2011-12-19 2011-12-19
PCT/US2012/070638 WO2013096458A1 (en) 2011-12-19 2012-12-19 Recombinant human alpha-1-antitrypsin for the treatment of inflammatory disorders

Publications (2)

Publication Number Publication Date
BR112014014751A2 BR112014014751A2 (en) 2017-06-13
BR112014014751A8 true BR112014014751A8 (en) 2017-07-04

Family

ID=48669451

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014014751A BR112014014751A8 (en) 2011-12-19 2012-12-19 composition comprising alpha-1-antitrypsin, mammary gland epithelial cells, transgenic non-human mammal, and method for reducing lung elastase activity

Country Status (10)

Country Link
US (1) US20140228301A1 (en)
EP (1) EP2793936A4 (en)
JP (1) JP2015502370A (en)
KR (1) KR20140132706A (en)
CN (1) CN104302312A (en)
AU (1) AU2012323992A1 (en)
BR (1) BR112014014751A8 (en)
CA (1) CA2858825A1 (en)
IL (1) IL233061A0 (en)
WO (1) WO2013096458A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3834851A1 (en) 2010-12-30 2021-06-16 Laboratoire Français du Fractionnement et des Biotechnologies Glycols as pathogen inactive agents
WO2014140927A2 (en) 2013-02-13 2014-09-18 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
ES2755181T3 (en) 2013-02-13 2020-04-21 Lab Francais Du Fractionnement Highly galactosylated anti-TNF-alpha antibodies and uses thereof
PL3016729T3 (en) 2013-07-05 2020-09-07 Laboratoire Français Du Fractionnement Et Des Biotechnologies Société Anonyme Affinity chromatography matrix
US20170354722A1 (en) * 2014-11-07 2017-12-14 Mor Research Applications Ltd. Compositions and methods for treating post-operative complications of cardiopulmonary surgery
CA2970993A1 (en) * 2015-01-08 2016-07-14 Apceth Gmbh & Co. Kg Genetically modified mesenchymal stem cells expressing alpha-1 antitrypsin (aat)
US11446366B2 (en) 2015-02-05 2022-09-20 Canem Holdings, Llc Compositions and methods for treating granulomatosis with polyangiitis
EP3402572B1 (en) 2016-01-13 2022-03-16 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions
WO2019105770A1 (en) 2017-11-28 2019-06-06 Danmarks Tekniske Universitet Glycosylation of proteins
US11859250B1 (en) 2018-02-23 2024-01-02 Children's Hospital Medical Center Methods for treating eosinophilic esophagitis
WO2019198070A1 (en) * 2018-04-08 2019-10-17 Kamada Ltd. Compositions and methods for treating inflammatory bowel diseases (ibds)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
WO2000030436A1 (en) * 1998-11-19 2000-06-02 Ppl Therapeutics (Scotland) Ltd. Stabilisation of milk from transgenic animals
BR0014860A (en) * 1999-10-14 2003-07-08 Genzyme Transgenics Corp Methods for producing a target molecule in a transgenic animal and purifying the target molecule
CA2501415A1 (en) * 2002-08-01 2004-02-12 Gtc Biotherapeutics, Inc. Method of selecting cells for somatic cell nuclear transfer
CU23102A1 (en) * 2002-10-21 2005-12-20 Ct Ingenieria Genetica Biotech METHOD FOR THE PRODUCTION OF RECOMBINANT PROTEINS IN THE MAMMARY GLAND OF NON-TRANSGENIC MAMMALS
EP2740487B1 (en) * 2006-02-09 2018-02-28 Kamada Ltd. Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases
US7531632B2 (en) * 2006-02-16 2009-05-12 Gtc Biotherapeutics, Inc. Clarification of transgenic milk using depth filtration
AU2010244592B2 (en) * 2009-04-23 2016-05-19 Janssen Vaccines & Prevention B.V. Recombinant human alpha1-antitrypsin
ES2332645B1 (en) * 2009-06-30 2010-10-18 Grifols, S.A. USE OF ALFA-1-ANTITRIPSIN FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME.

Also Published As

Publication number Publication date
CN104302312A (en) 2015-01-21
US20140228301A1 (en) 2014-08-14
EP2793936A4 (en) 2015-05-27
JP2015502370A (en) 2015-01-22
IL233061A0 (en) 2014-07-31
WO2013096458A1 (en) 2013-06-27
EP2793936A1 (en) 2014-10-29
AU2012323992A1 (en) 2013-07-04
KR20140132706A (en) 2014-11-18
BR112014014751A2 (en) 2017-06-13
CA2858825A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
BR112014014751A2 (en) composition comprising alpha-1-antitrypsin, mammary gland epithelial cells, transgenic non-human mammal, and method for reducing lung elastase activity
DK2675510T3 (en) STOP MECHANISM
BR112013033506A2 (en) linear actuator
FR2978516B1 (en) DOUBLE ACTION LINEAR ACTUATOR
DK2709197T3 (en) solid oxide fuel cell
DE102012110637A8 (en) Linear Actuator
FR2979475B1 (en) LINEAR ACTUATOR
GB201100046D0 (en) Automated techniques for manufacturing fibrous panels
FR2977649B1 (en) LINEAR ACTUATOR
DE112012000803A5 (en) actuator
DK2610053T3 (en) Sandwich Core Materials
FR2972076B1 (en) MAGNETOTHERMIC ACTUATOR.
DE112011103981A5 (en) actuator
FR2970943B1 (en) BLADE AND METHOD FOR MANUFACTURING THE SAME
BR112014014169A2 (en) automatic valve
BR112014000002A2 (en) gate valve
DK2681310T4 (en) HAPLOID EMBRYONIC MAMMAL STEM CELLS
DE112012001239A5 (en) attenuator
DE112012000756A5 (en) attenuator
FR2978919B1 (en) MULTIVOIE PILOT BOX
EP2682464A4 (en) Fibrinogen-producing transgenic silkworm
BR112013015487A2 (en) carotenoid-related compositions and methods.
DK2351954T3 (en) Valve
DE112012003400A5 (en) Actuator for a clutch
FI20116210L (en) Improved Benchmark

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]